Hologic (HOLX +1.6%) ticks higher after JPMorgan ups the shares to Overweight. The firm says the...

|By:, SA News Editor

Hologic (HOLX +1.6%) ticks higher after JPMorgan ups the shares to Overweight. The firm says the upgrade was made to reflect compelling risk/reward and synergies from the Gen-Probe (GPRO) deal. Its price target is also raised to $22 from $20.